Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Utkarsh H. Acharya, Tejaswini Dhawale, Seongseok Yun, Caron A. Jacobson, Julio C. Chavez, Jorge D. Ramos, Jacob Appelbaum & David G. Maloney. (2019) Management of cytokine release syndrome and neurotoxicity in chimeric antigen receptor (CAR) T cell therapy. Expert Review of Hematology 12:3, pages 195-205.
Read now
Read now
Giuseppe Gaipa, Chiara Buracchi & A Biondi. (2018) Flow cytometry for minimal residual disease testing in acute leukemia: opportunities and challenges. Expert Review of Molecular Diagnostics 18:9, pages 775-787.
Read now
Read now
Paola Circosta, Angela Rita Elia, Indira Landra, Rodolfo Machiorlatti, Maria Todaro, Sabrina Aliberti, Davide Brusa, Silvia Deaglio, Sabina Chiaretti, Riccardo Bruna, Daniela Gottardi, Massimo Massaia, Filomena Di Giacomo, Anna Rita Guarini, Robin Foà, Peter W. Kyriakides, Rohan Bareja, Olivier Elemento, Gurunadh R. Chichili, Emanuele Monteleone, Paul A. Moore, Syd Johnson, Ezio Bonvini, Alessandro Cignetti & Giorgio Inghirami. (2018) Tailoring CD19xCD3-DART exposure enhances T-cells to eradication of B-cell neoplasms. OncoImmunology 7:4.
Read now
Read now
Josep-Maria Ribera, Albert Ferrer, Jordi Ribera & Eulàlia Genescà. (2015) Profile of blinatumomab and its potential in the treatment of relapsed/refractory acute lymphoblastic leukemia. OncoTargets and Therapy 8, pages 1567-1574.
Read now
Read now
Articles from other publishers (17)
Yunlin Zhang, Ruchi P. Patel, Ki Hyun Kim, Hyungwoo Cho, Jae-Cheol Jo, Seong Hyun Jeong, Sung Yong Oh, Yoon Seok Choi, Sung Hyun Kim, Ji Hyun Lee, Mathew Angelos, Puneeth Guruprasad, Ivan Cohen, Ositadimma Ugwuanyi, Yong Gu Lee, Raymone Pajarillo, Jong Hyun Cho, Alberto Carturan, Luca Paruzzo, Guido Ghilardi, Michael Wang, Soohwan Kim, Sung-Min Kim, Hyun-Jong Lee, Ji-Ho Park, Leiguang Cui, Tae Bum Lee, In-Sik Hwang, Young-Ha Lee, Yong-Jun Lee, Patrizia Porazzi, Dongfang Liu, Yoon Lee, Jong-Hoon Kim, Jong-Seo Lee, Dok Hyun Yoon, Junho Chung & Marco Ruella. (2023) Safety and efficacy of a novel anti-CD19 chimeric antigen receptor T cell product targeting a membrane-proximal domain of CD19 with fast on- and off-rates against non-Hodgkin lymphoma: a first-in-human study. Molecular Cancer 22:1.
Crossref
Crossref
Yong Gu Lee, Nicholas Yang, Inkook Chun, Patrizia Porazzi, Alberto Carturan, Luca Paruzzo, Christopher Tor Sauter, Puneeth Guruprasad, Raymone Pajarillo & Marco Ruella. (2023)
Apoptosis: a
Janus bifrons
in T-cell immunotherapy
. Journal for ImmunoTherapy of Cancer 11:4, pages e005967.
Crossref
Crossref
Yong Gu Lee, Puneeth Guruprasad, Guido Ghilardi, Raymone Pajarillo, Christopher Tor Sauter, Ruchi Patel, Hatcher J. Ballard, Seok Jae Hong, Inkook Chun, Nicholas Yang, Kimberly V. Amelsberg, Katherine D. Cummins, Jakub Svoboda, Saar Gill, Elise A. Chong, Khrystyna North, Sarah E. Church, Joseph A. Fraietta, Wan-Jung Chang, Simon F. Lacey, Xueqing Maggie Lu, Yunlin Zhang, Kanupriya Whig, David C. Schultz, Sara Cherry, James Gerson, Stephen J. Schuster, Patrizia Porazzi & Marco Ruella. (2022) Modulation of BCL-2 in Both T Cells and Tumor Cells to Enhance Chimeric Antigen Receptor T-cell Immunotherapy against Cancer. Cancer Discovery 12:10, pages 2372-2391.
Crossref
Crossref
Sisi Wang, Lijun Peng, Wenqian Xu, Yuebo Zhou, Ziyan Zhu, Yushan Kong, Stewart Leung, Jin Wang, Xiaoqiang Yan & Jian-Qing Mi. (2021) Preclinical characterization and comparison between CD3/CD19 bispecific and novel CD3/CD19/CD20 trispecific antibodies against B-cell acute lymphoblastic leukemia: targeted immunotherapy for acute lymphoblastic leukemia. Frontiers of Medicine 16:1, pages 139-149.
Crossref
Crossref
Lijun Xu, Shanlong Wang, Jie Li & Bingyu Li. (2019) CD47/SIRPα blocking enhances CD19/CD3-bispecific T cell engager antibody-mediated lysis of B cell malignancies. Biochemical and Biophysical Research Communications 509:3, pages 739-745.
Crossref
Crossref
De-Xiu Bu, Reshma Singh, Eugene E. Choi, Marco Ruella, Selene Nunez-Cruz, Keith G. Mansfield, Paul Bennett, Nathanial Barton, Qilong Wu, Jiquan Zhang, Yongqiang Wang, Lai Wei, Shawn Cogan, Tucker Ezell, Shree Joshi, Kellie J. Latimer, Brian Granda, William R. Tschantz, Regina M. Young, Heather A. Huet, Celeste J. Richardson & Michael C. Milone. (2018) Pre-clinical validation of B cell maturation antigen (BCMA) as a target for T cell immunotherapy of multiple myeloma. Oncotarget 9:40, pages 25764-25780.
Crossref
Crossref
William R. Strohl. (2017) Current progress in innovative engineered antibodies. Protein & Cell 9:1, pages 86-120.
Crossref
Crossref
Marjan Abedi & Zohre Khosravi Dehaghi. (2017) Immunotherapy for Acute Lymphoblastic Leukemia: Challenge and Promise. Focus on Sciences 3:4, pages 1-6.
Crossref
Crossref
Marco Pizzi & Giorgio Inghirami. (2017) Patient-derived tumor xenografts of lymphoproliferative disorders. Current Opinion in Hematology 24:4, pages 384-392.
Crossref
Crossref
M. Pizzi & G. Inghirami. 2017. Patient Derived Tumor Xenograft Models. Patient Derived Tumor Xenograft Models
305
339
.
Marco Ruella, David M. Barrett, Saad S. Kenderian, Olga Shestova, Ted J. Hofmann, Jessica Perazzelli, Michael Klichinsky, Vania Aikawa, Farzana Nazimuddin, Miroslaw Kozlowski, John Scholler, Simon F. Lacey, Jan J. Melenhorst, Jennifer J.D. Morrissette, David A. Christian, Christopher A. Hunter, Michael Kalos, David L. Porter, Carl H. June, Stephan A. Grupp & Saar Gill. (2016) Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapies. Journal of Clinical Investigation 126:10, pages 3814-3826.
Crossref
Crossref
Marco Ruella & Carl H. June. (2016) Chimeric Antigen Receptor T cells for B Cell Neoplasms: Choose the Right CAR for You. Current Hematologic Malignancy Reports 11:5, pages 368-384.
Crossref
Crossref
M Pizzi, M Boi, F Bertoni & G Inghirami. (2016) Emerging therapies provide new opportunities to reshape the multifaceted interactions between the immune system and lymphoma cells. Leukemia 30:9, pages 1805-1815.
Crossref
Crossref
Michael Hettich, Jayashree Lahoti, Shruthi Prasad & Gabriele Niedermann. (2016) Checkpoint Antibodies but not T Cell–Recruiting Diabodies Effectively Synergize with TIL-Inducing γ-Irradiation. Cancer Research 76:16, pages 4673-4683.
Crossref
Crossref
Marco Ruella, Saad S. Kenderian, Olga Shestova, Joseph A. Fraietta, Sohail Qayyum, Qian Zhang, Marcela V. Maus, Xiaobin Liu, Selene Nunez-Cruz, Michael Klichinsky, Omkar U. Kawalekar, Michael Milone, Simon F. Lacey, Anthony Mato, Stephen J. Schuster, Michael Kalos, Carl H. June, Saar Gill & Mariusz A. Wasik. (2016) The Addition of the BTK Inhibitor Ibrutinib to Anti-CD19 Chimeric Antigen Receptor T Cells (CART19) Improves Responses against Mantle Cell Lymphoma. Clinical Cancer Research 22:11, pages 2684-2696.
Crossref
Crossref
Marco Ruella & Marcela V. Maus. (2016) Catch me if you can: Leukemia Escape after CD19-Directed T Cell Immunotherapies. Computational and Structural Biotechnology Journal 14, pages 357-362.
Crossref
Crossref
Jason B. Kaplan, Marina Grischenko & Francis J. Giles. (2015) Blinatumomab for the treatment of acute lymphoblastic leukemia. Investigational New Drugs 33:6, pages 1271-1279.
Crossref
Crossref